Top Stories
-
With new microneedles in development at Columbia University, delivering precise doses of drugs to the inner ear without risking permanent hearing damage may soon be possible.
-
The first-ever detailed images of a malaria protein, a key modulator of drug resistance, show how the parasite evades antimalarials—and may help scientists find ways to restore the drugs’ potency.
Topic
-
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
Topic
-
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
Topic
Latest News
- August 8, 2018
A new way to conduct health studies by tapping the troves of data held in electronic health records may speed medical research and reduce the frequency of conflicting findings.
- August 2, 2018
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
Topic
- July 30, 2018
Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
Topic
- July 27, 2018
A new National Academies report—co-authored by Columbia Nursing’s Suzanne Bakken—recommends returning health information gathered during research to study participants.
Topic
- June 19, 2018
Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Topic
- June 18, 2018
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2018 Gerstner Scholars and a fifth has been named a Gerstner Merit Awardee.
Topic
- May 31, 2018
Three Vagelos P&S medical students have been awarded year-long biomedical research fellowships from the Howard Hughes Medical Institute.
Topic
- May 22, 2018
CUIMC has a new clinic and research program for women with a rare form of osteoporosis associated with pregnancy.
Topic
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
Topic
- May 3, 2018
Neuroscientist Carol Mason, PhD, was elected to the National Academy of Sciences along with 104 other new members and foreign associates.
Topic
